器官移植术后耐药菌感染诊疗技术规范（2019版）

中华医学会器官移植学分会

doi:10.3969/j.issn.1674-7445.2019.04.002

器官移植术后耐药菌感染诊疗技术规范（2019版）

doi: 10.3969/j.issn.1674-7445.2019.04.002

中华医学会器官移植学分会^,

100091 北京，中国人民解放军总医院第八医学中心（李钢、石炳毅）；广州医科大学第一医院（巨春蓉）

基金项目:

国家自然科学基金 81570680

国家自然科学基金 81571555

详细信息

通讯作者:
石炳毅，Email：shibingyi666@126.com

中图分类号: R617, R619.3
计量
- 文章访问数: 364
- HTML全文浏览量: 98
- PDF下载量: 170
- 被引次数: 0
出版历程
- 收稿日期: 2019-04-16
- 网络出版日期: 2021-01-19
- 刊出日期: 2019-07-15

Technical specification for diagnosis and treatment of drug-resistant bacterial infection after organ transplantation (2019 edition)

Branch of Organ Transplantation of Chinese Medical Association^,

摘要

摘要: 为了进一步规范实体器官移植术后耐药菌感染的诊断和治疗，中华医学会器官移植学分会组织器官移植学专家和感染学专家，从实体器官移植术后耐药菌感染的情况、国内细菌感染及耐药情况、多重耐药菌感染的抗生素治疗等方面，制订实体器官移植术后耐药菌感染的诊疗技术规范。
- 器官移植 /
- 感染 /
- 耐药菌 /
- 多重耐药 /
- 泛耐药 /
- 全耐药 /
- 耐甲氧西林金黄色葡萄球菌 /
- 泛耐药鲍曼不动杆菌 /
- 替加环素

HTML全文

图 1 历年革兰阴性菌和革兰阳性菌菌株数及所占比例

Figure 1. Strains and proportion of Gram-negative and Gram-positive bacteria in the past years

下载: 全尺寸图片幻灯片

图 2 190 610株临床分离菌在各类标本中的分布

Figure 2. Distribution of 190 610 strains of clinical isolates bacteria in various specimens

下载: 全尺寸图片幻灯片

图 3 2017年主要临床分离菌分布（前20位）

Figure 3. Distribution of major clinical isolates of bacteria in 2017 (top 20)

下载: 全尺寸图片幻灯片

图 4 MRSA和MRCNS的检出率近13年变迁

Figure 4. Changes of detection rate of MRSA and MRCNS in the past 13 years

下载: 全尺寸图片幻灯片

图 5 36 635株尿道标本分离菌主要菌种分布

Figure 5. Distribution of main bacteria isolated from 36 635 strains of urethral specimens

下载: 全尺寸图片幻灯片

图 6 36 735株大肠埃希菌对抗菌药的耐药率

Figure 6. Drug resistance rate of 36 735 strains of escherichia coli to antimicrobial agents

下载: 全尺寸图片幻灯片

图 7 76 333株呼吸道标本分离菌主要菌种分布

Figure 7. Distribution of major bacteria isolated from 76 333 strains of respiratory tract specimens

下载: 全尺寸图片幻灯片

图 8 27 977株肺炎克雷伯菌对抗生素的耐药率

Figure 8. Antibiotic resistance rate of 27 977 strains of Klebsiella pneumoniae

下载: 全尺寸图片幻灯片

参考文献(21)

[1]	HU FP, GUO Y, ZHU DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014[J]. Clin Microbiol Infect, 2016, 22 (Suppl 1): S9-S14. DOI: 10.1016/j.cmi.2016.01.001.
[2]	SEN A, CALLISEN H, LIBRICZ S, et al. Complications of solid organ transplantation: cardiovascular, neurologic, renal, and gastrointestinal[J]. Crit Care Clin, 2019, 35(1):169-186. DOI: 10.1016/j.ccc.2018.08.011.
[3]	GARNACHO-MONTERO J, AMAYA-VILLAR R. Multiresistant acinetobacter baumannii infections: epidemiologyand management[J]. Curr Opin Infect Dis, 2010, 23(4):332-339. DOI: 10.1097/QCO.0b013e32833ae38b.
[4]	杨富, 陈兰, 方芳, 等.肝移植术后多重耐药菌感染危险因素的系统评价[J].上海交通大学学报(医学版), 2015, 35(7):1015-1022.DOI: 11.3969/j.issn.1674-8115.2015.07.016. YANG F, CHEN L, FANG F, et al. Systematic evaluation of risk factors of multi-drug resistant organisms infection after liver transplantation[J]. J Shanghai Jiaotong Univ (Med Sci), 2015, 35(7):1015-1022. DOI: 11.3969/j.issn.1674-8115.2015.07.016.
[5]	QIN X, YANG Y, HU F, et al. Hospital clonal dissemination of Enterobacter aerogenes producing carbapenemase KPC-2in a Chinese teaching hospital[J]. J Med Microbiol, 2014, 63(Pt 2):222-228. DOI: 10.1099/jmm.0.064865-0.
[6]	李智斌, 张更, 刘克普, 等.公民逝世后器官捐献肾移植早期多重耐药菌感染的临床研究[J].器官移植, 2017, 8(5):386-391.DOI: 10.3969/j.issn.1674-7445.2017.05.010. LI ZB, ZHANG G, LIU KP, et al. Clinical study of early infection of multi-drug resistant organisms after renal transplantation from organ donation after citizen's death[J]. Organ Transplant, 2017, 8(5):386-391. DOI: 10.3969/j.issn.1674-7445.2017.05.010.
[7]	GALVÃO LM, OLIVEIRA APR, IBANÊS AS, et al. Fatal case of donor-derived colistin-resistant carbapenemase-producing Klebsiella pneumoniae transmission in cardiac transplantation[J]. Braz J Infect Dis, 2018, 22(3):235-238. DOI: 10.1016/j.bjid.2018.04.005.
[8]	Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[M]. 27th ed. Wayle: Clinical and Laboratory Standards Institute, 2017.
[9]	胡付品, 郭燕, 朱德妹, 等. 2017年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志, 2018, 18(3):241-251. DOI: 10.16718/j.1009-7708.2018.03.001. HU FP, GUO Y, ZHU DM, et al. CHINET surveillance of bacterial resistance across China: report of the results in 2017[J]. Chin J Infect Chemoth, 2018, 18(3):241-251. DOI: 10.16718/j.1009-7708.2018.03.001.
[10]	高建, 张媛, 成伟丽, 等.器官捐献移植肾动脉细菌感染破裂的诊疗对策[J].器官移植, 2017, 8(4):311-313, 332. DOI: 10.3969/j.issn.1674-7445.2017.04.012. GAO J, ZHANG Y, CHENG WL, et al. Diagnosis and treatment on renal artery rupture of transplant kidney caused by bacterial infection after organ donation[J]. Organ Transplant, 2017, 8(4):311-313, 332. DOI: 10.3969/j.issn.1674-7445.2017.04.012.
[11]	胡付品, 郭燕, 朱德妹, 等. 2016年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志, 2017, 17(5):481-491. DOI: 10.16718/j.1009-7708.2017.05.001. HU FP, GUO Y, ZHU DM, et al. CHINET surveillance of bacterial resistance across China: report of the results in 2016[J]. Chin J Infect Chemoth, 2017, 17(5):481-491. DOI: 10.16718/j.1009-7708.2017.05.001.
[12]	ZHANG R, LIU L, ZHOU H, et al. Nationwide surveillance of clinical carbapenem-resistant enterobacteriaceae (CRE) strains in China[J]. EBioMedicine, 2017, 19:98-106. DOI: 10.1016/j.ebiom.2017.04.032.
[13]	VAROTTI G, DODI F, TERULLA A, et al. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation[J]. Transpl Infect Dis, 2017, 19(6). DOI: 10.1111/tid.12757.
[14]	SIMKINS J, MUGGIA V, COHEN HW, et al. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study[J]. Transpl Infect Dis, 2014, 16(5):775-782. DOI: 10.1111/tid.12276.
[15]	BURCKHARDT I, LAST K, ZIMMERMANN S. Shorter incubation times for detecting multi-drug resistant bacteria in patient samples: defining early imaging time points using growth kinetics and total laboratory automation[J]. Ann Lab Med, 2019, 39(1):43-49. DOI: 10.3343/alm.2019.39.1.43.
[16]	王明贵.广泛耐药革兰阴性菌感染的实验诊断、抗菌治疗及医院感染控制:中国专家共识[J].中国感染与化疗杂志, 2017, 17(1):82-93. DOI: 10.16718/j.1009-7708.2017.01.015. WANG MG. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement[J]. Chin J Infect Chemoth, 2017, 17(1):82-93. DOI: 10.16718/j.1009-7708.2017.01.015.
[17]	POUCH SM, KUBIN CJ, SATLIN MJ, et al. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients[J]. Transpl Infect Dis, 2015, 17(6):800-809. DOI: 10.1111/tid.12450.
[18]	BIAS TE, MALAT GE, LEE DH, et al. Clinical outcomes associated with carbapenem resistant Klebsiella pneumoniae (CRKP) in abdominal solid organ transplant (SOT) recipients[J]. Infect Dis (Lond), 2018, 50(1):67-70. DOI: 10.1080/23744235.2017.1354259.
[19]	KENGKLA K, KONGPAKWATTANA K, SAOKAEW S, et al. Comparative efficacy and safety of treatment options for MDR and XDR acinetobacter baumannii infections: a systematic review and network Meta-analysis[J]. J Antimicrob Chemother, 2018, 73(1):22-32. DOI: 10.1093/jac/dkx368.
[20]	SCHWABER MJ, CARMELI Y. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae[J]. Clin Infect Dis, 2014, 58(5):697-703. DOI: 10.1093/cid/cit795.
[21]	LAGACÉ-WIENS P, WALKTY A, KARLOWSKY JA. Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections[J]. Core Evid, 2014, 9:13-25. DOI: 10.2147/CE.S40698.